Impact of combined C1 esterase inhibitor/coagulation factor XIII or N-acetylcysteine/tirilazad mesylate administration on leucocyte adherence and cytokine release in experimental endotoxaemia

J Int Med Res. 2008 Jul-Aug;36(4):748-59. doi: 10.1177/147323000803600417.

Abstract

We determined the effects of combinations of C1 esterase inhibitor (C1-INH) with factor XIII and of N-acetylcysteine (NAC) with tirilazad mesylate (TM) during lipo-polysaccharide (LPS)-induced endotoxaemia in rats. Forty Wistar rats were divided into four groups: the control (CON) group received no LPS; the LPS, C1-INH + factor XIII and NAC + TM groups received endotoxin infusions (5 mg/kg per h). After 30 min of endotoxaemia, 100 U/kg C1-INH + 50 U/kg factor XIII was administered to the C1-INH + factor XIII group, and 150 mg/kg NAC + 10 mg/kg TM was administered in the NAC + TM group. Administration of C1-INH + factor XIII and NAC + TM both resulted in reduced leucocyte adherence and reduced levels of interleukin-1beta (IL-1beta). The LPS-induced increase in IL-6 levels was amplified by both drug combinations. There was no significant effect on mesenteric plasma extravasation. In conclusion, the administration of C1-INH + factor XIII and NAC + TM reduced endothelial leucocyte adherence and IL-1beta plasma levels, but increased IL-6 levels.

MeSH terms

  • Acetylcysteine / therapeutic use*
  • Animals
  • Antioxidants / therapeutic use
  • Cell Adhesion / physiology
  • Complement C1 Inhibitor Protein / therapeutic use*
  • Cytokines / blood*
  • Cytokines / immunology
  • Drug Therapy, Combination
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / metabolism
  • Endotoxemia* / drug therapy
  • Endotoxemia* / immunology
  • Factor XIII / therapeutic use*
  • Humans
  • Leukocytes / cytology
  • Leukocytes / metabolism*
  • Male
  • Pregnatrienes / therapeutic use*
  • Random Allocation
  • Rats
  • Rats, Wistar

Substances

  • Antioxidants
  • Complement C1 Inhibitor Protein
  • Cytokines
  • Pregnatrienes
  • Factor XIII
  • Acetylcysteine
  • tirilazad